शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEChoksi Asia Ltd· Healthcare Equipment & SuppliesHighNeutral
Announced Thu, 13 Nov, 2025 · 13:43 IST

Outcome of Board Meeting.

Revenue growth above 20%Profit growth above 25%Negative operating cash flowResults restatedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹106.50
prior close
₹107.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+1.5% vs market
Medical Equipment & Supplies peers, median of 14sector-1.9%+3.3% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 3.3 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
+4.4
15m
+1.9
30m
+0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4-0.1+1.5-1.9+3.3
Next day
+0.8-0.2+1.0-2.3+3.1
2d
+6.0+0.4+5.5-4.1+10.1
3d
+11.2-0.4+11.6-4.8+16.1
4d
+11.9-0.6+12.5-5.7+17.6
5d
+8.0-0.9+8.9-6.2+14.2
1w
+0.5-3.0+3.5-11.2+11.6
15d
+4.6-3.9+8.4-10.0+14.6
1m
+22.1-4.8+26.9-8.0+30.0
2m
+5.2-7.8+12.9-15.7+20.9
3m
+19.2-7.2+26.5-25.9+45.2
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 14Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Choksi Asia Ltd reported strong Q2 FY26 results with revenue from operations of ₹1,329.23 lakhs, up about 58% from ₹841.98 lakhs in Q2 FY25. Net profit after tax more than doubled to ₹134.65 lakhs (vs ₹65.02 lakhs), translating to EPS of ₹2.36 vs ₹1.14. For the half-year, revenue rose to ₹2,518.98 lakhs (vs ₹1,616.16 lakhs) while PAT grew to ₹242.08 lakhs (vs ₹218.31 lakhs). Total expenses climbed faster than revenue, with cost of materials and stock-in-trade purchases rising sharply. The auditor (Karia & Shah) issued an unqualified limited review report. Comparative figures were restated to give effect to the amalgamation of Choksi Asia Pvt Ltd with the company from April 1, 2023.

Likely market impact

Sharp top-line and bottom-line growth in Q2 is positive for shareholders, but operating cash flow was negative ₹49.65 lakhs in H1 due to a spike in trade receivables, which is a yellow flag despite strong reported profits. Borrowings remain low and equity is healthy, so the overall picture is constructive but watch for working-capital strain.